Petrova Penka
Chief Development Officer at Trillium Therapeutics Inc.
- Sold, on record
- $280k
- Dollars the filings state
- Form 4 sales
- 6
- Latest Apr 8, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Trillium Therapeutics Inc.Chief Development Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Trillium Therapeutics Inc.UnusualJan 7, 2021 2021
Sold 2,708 shares at $14.71 ($40k)
Petrova Penka, Chief Development Officer
Sold 100% of holdings ($40k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale Trillium Therapeutics Inc.UnusualJan 8, 2021 +1 day
Sold 2,604 shares at $15.50 ($40k)
Petrova Penka, Chief Development Officer
Sold 100% of holdings ($40k position)0 shares leftFiling
- 3 Form 4 sale Trillium Therapeutics Inc.UnusualJan 11, 2021 +3 days
Sold 508 shares at $15.21 ($8k)
Petrova Penka, Chief Development Officer
Sold 100% of holdings ($8k position)0 shares leftFiling
- 4 Form 4 sale Trillium Therapeutics Inc.UnusualFeb 9, 2021 +29 days
Sold 5,820 shares at $12.78 ($74k)
Petrova Penka, Chief Development Officer
Sold 100% of holdings ($74k position)0 shares left2.2x usual sizeFiling
- 5 Form 4 sale Trillium Therapeutics Inc.UnusualMar 10, 2021 +29 days
Sold 5,312 shares at $11.08 ($59k)
Petrova Penka, Chief Development Officer
Sold 100% of holdings ($59k position)0 shares left2x usual sizeFiling
- 6 Form 4 sale Trillium Therapeutics Inc.UnusualApr 8, 2021 +29 days
Sold 5,312 shares at $11.09 ($59k)
Petrova Penka, Chief Development Officer
Sold 100% of holdings ($59k position)0 shares left2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2021 | Apr 9, 2021 | Trillium Therapeutics Inc. | Chief Development Officer | Form 4 sale | 5,312 | $59k | 100.0% | Unusual | SEC |
| Mar 10, 2021 | Mar 12, 2021 | Trillium Therapeutics Inc. | Chief Development Officer | Form 4 sale | 5,312 | $59k | 100.0% | Unusual | SEC |
| Feb 9, 2021 | Feb 10, 2021 | Trillium Therapeutics Inc. | Chief Development Officer | Form 4 sale | 5,820 | $74k | 100.0% | Unusual | SEC |
| Jan 11, 2021 | Jan 13, 2021 | Trillium Therapeutics Inc. | Chief Development Officer | Form 4 sale | 508 | $8k | 100.0% | Unusual | SEC |
| Jan 8, 2021 | Jan 12, 2021 | Trillium Therapeutics Inc. | Chief Development Officer | Form 4 sale | 2,604 | $40k | 100.0% | Unusual | SEC |
| Jan 7, 2021 | Jan 11, 2021 | Trillium Therapeutics Inc. | Chief Development Officer | Form 4 sale | 2,708 | $40k | 100.0% | Unusual | SEC |